• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能受损进一步增加了 1 型糖尿病成人 6 年内冠状动脉钙化进展的几率:CACTI 研究。

Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study.

机构信息

Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA.

出版信息

Diabetes Care. 2013 Sep;36(9):2607-14. doi: 10.2337/dc12-2538. Epub 2013 Jul 8.

DOI:10.2337/dc12-2538
PMID:23835686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3747879/
Abstract

OBJECTIVE

To determine whether baseline estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR) independently predict coronary artery calcification (CAC) progression, and to determine how eGFR changes over 6 years in adults with type 1 diabetes compared with nondiabetic adults.

RESEARCH DESIGN AND METHODS

The Coronary Artery Calcification in Type 1 Diabetes study participants (n = 1,066) with complete data for eGFR assessment at baseline and 6 years were included. Three Chronic Kidney Disease Epidemiology Collaboration equations (serum creatinine, cystatin C, and both) were used to estimate eGFR. The association of baseline ACR and eGFR with CAC progression was analyzed using multiple logistic regression.

RESULTS

Increasing categorical baseline ACR (<10, 10-30, and >30 µg/mg) predicted CAC progression in participants with type 1 diabetes (odds ratio [OR], 2.15; 95% CI, 1.50-3.09; 7.19 [3.90-13.26]; and 18.09 [8.48-38.62]), respectively, compared with nondiabetic subjects. Baseline eGFR <60 mL/min/1.73 m(2) also predicted CAC progression (OR, 5-7, compared with nondiabetic participants). ORs for CAC progression were higher in women than in men when using the cystatin C-based Chronic Kidney Disease Epidemiology Collaboration equations. Participants with type 1 diabetes had greater eGFR decreases over 6 years than nondiabetic participants using cystatin C-based equations.

CONCLUSIONS

Although increasing ACR or decreasing eGFR predicts CAC progression, coronary atherosclerosis progresses faster in people with type 1 diabetes even in the absence of diabetic kidney disease. These findings emphasize the interaction between kidney disease and cardiovascular disease in type 1 diabetes and highlight the public health importance of lowering cardiorenal risk in people with type 1 diabetes.

摘要

目的

确定基线估算肾小球滤过率(eGFR)和白蛋白与肌酐比值(ACR)是否独立预测冠状动脉钙化(CAC)进展,并确定 1 型糖尿病成人与非糖尿病成人相比,6 年内 eGFR 的变化情况。

研究设计和方法

本研究纳入了冠状动脉钙化在 1 型糖尿病研究(n=1066)中基线和 6 年时 eGFR 评估数据完整的参与者。使用 3 种慢性肾脏病流行病学合作组方程(血清肌酐、胱抑素 C 和两者)来估计 eGFR。使用多因素逻辑回归分析基线 ACR 和 eGFR 与 CAC 进展的相关性。

结果

与非糖尿病受试者相比,1 型糖尿病患者中,递增的基线 ACR(<10、10-30 和>30 µg/mg)分别预测 CAC 进展(比值比[OR],2.15;95%可信区间[CI],1.50-3.09;7.19 [3.90-13.26];18.09 [8.48-38.62])。基线 eGFR <60 mL/min/1.73 m(2) 也预测 CAC 进展(OR,5-7,与非糖尿病参与者相比)。使用基于胱抑素 C 的慢性肾脏病流行病学合作组方程时,女性的 CAC 进展 OR 高于男性。与非糖尿病参与者相比,1 型糖尿病患者使用基于胱抑素 C 的方程时,eGFR 在 6 年内下降幅度更大。

结论

尽管 ACR 升高或 eGFR 降低预测 CAC 进展,但即使在没有糖尿病肾病的情况下,1 型糖尿病患者的冠状动脉粥样硬化进展更快。这些发现强调了 1 型糖尿病中肾脏疾病和心血管疾病之间的相互作用,并突出了降低 1 型糖尿病患者心肾风险的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9400/3747879/2bd4155d4206/2607fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9400/3747879/2bd4155d4206/2607fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9400/3747879/2bd4155d4206/2607fig1.jpg

相似文献

1
Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study.肾功能受损进一步增加了 1 型糖尿病成人 6 年内冠状动脉钙化进展的几率:CACTI 研究。
Diabetes Care. 2013 Sep;36(9):2607-14. doi: 10.2337/dc12-2538. Epub 2013 Jul 8.
2
Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.血清尿调蛋白可预测 1 型糖尿病成人在 12 年内冠状动脉钙化和糖尿病肾脏疾病的发生率较低:CACTI 研究。
Diabetes Care. 2019 Feb;42(2):297-302. doi: 10.2337/dc18-1527. Epub 2018 Nov 27.
3
Chronic kidney disease and coronary artery calcification in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).巴西成人健康纵向研究(ELSA-Brasil)中的慢性肾脏病与冠状动脉钙化
Clin Cardiol. 2017 Dec;40(12):1309-1315. doi: 10.1002/clc.22829. Epub 2017 Dec 15.
4
Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.1 型糖尿病成人早期肾功能下降的预测因素:1 型糖尿病冠状动脉钙化和匹兹堡糖尿病并发症流行病学研究。
Diabet Med. 2017 Nov;34(11):1532-1540. doi: 10.1111/dme.13430. Epub 2017 Aug 14.
5
Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes.在1型糖尿病成人患者中,肾小球滤过率(GFR)快速下降与肾脏高滤过及GFR受损有关。
Nephrol Dial Transplant. 2015 Oct;30(10):1706-11. doi: 10.1093/ndt/gfv121. Epub 2015 Jun 6.
6
Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.血浆生物标志物可改善 12 年随访期间 1 型糖尿病成人糖尿病肾病的预测:CACTI 研究。
Nephrol Dial Transplant. 2018 Jul 1;33(7):1189-1196. doi: 10.1093/ndt/gfx255.
7
Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes.在1型糖尿病成人患者中, copeptin水平升高与动脉粥样硬化及糖尿病肾病相关。
J Diabetes Complications. 2016 Aug;30(6):1093-6. doi: 10.1016/j.jdiacomp.2016.04.012. Epub 2016 Apr 19.
8
Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.血清胱抑素C可预测1型糖尿病患者亚临床冠状动脉粥样硬化的进展。
Diabetes. 2007 Nov;56(11):2774-9. doi: 10.2337/db07-0539. Epub 2007 Jul 27.
9
Kidney function and progression of coronary artery calcium in community-dwelling older adults (from the Rancho Bernardo Study).社区居住的老年人的肾功能与冠状动脉钙进展(来自 Rancho Bernardo 研究)。
Am J Cardiol. 2012 Nov 15;110(10):1425-33. doi: 10.1016/j.amjcard.2012.06.053. Epub 2012 Aug 8.
10
Body mass index, coronary artery calcification, and kidney function decline in stage 3 to 5 chronic kidney disease patients.体重指数、冠状动脉钙化和 3 至 5 期慢性肾脏病患者的肾功能下降。
J Ren Nutr. 2013 Jan;23(1):4-11. doi: 10.1053/j.jrn.2011.12.008. Epub 2012 Apr 28.

引用本文的文献

1
Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes.1型糖尿病患者临床前期动脉粥样硬化进展的相关因素。
J Clin Med. 2025 Aug 25;14(17):6004. doi: 10.3390/jcm14176004.
2
Screening for Subclinical Atherosclerosis and the Prediction of Cardiovascular Events in People with Type 1 Diabetes.1型糖尿病患者亚临床动脉粥样硬化的筛查及心血管事件的预测
J Clin Med. 2024 Feb 15;13(4):1097. doi: 10.3390/jcm13041097.
3
Longitudinal associations of physical activity with inflammatory markers in US adults with and without type 1 diabetes.

本文引用的文献

1
Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study.降低尿酸以预防糖尿病患者的肾功能丧失:预防早期肾功能丧失(PERL)别嘌醇研究。
Curr Diab Rep. 2013 Aug;13(4):550-9. doi: 10.1007/s11892-013-0381-0.
2
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.1 型糖尿病成人的心血管疾病风险和全因死亡率:苏格兰登记处关联研究。
PLoS Med. 2012;9(10):e1001321. doi: 10.1371/journal.pmed.1001321. Epub 2012 Oct 2.
3
Kidney function and progression of coronary artery calcium in community-dwelling older adults (from the Rancho Bernardo Study).
美国 1 型糖尿病患者和非糖尿病患者身体活动与炎症标志物的纵向关联。
Diabetes Res Clin Pract. 2023 Dec;206:110978. doi: 10.1016/j.diabres.2023.110978. Epub 2023 Oct 25.
4
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes.循环小非编码 RNA 谱分析作为 1 型糖尿病动脉粥样硬化斑块成分的潜在生物标志物。
Diabetes Care. 2023 Mar 1;46(3):551-560. doi: 10.2337/dc22-1441.
5
Early functional and metabolic disorders in children with type I diabetes mellitus and diabetic nephropathy.I 型糖尿病合并糖尿病肾病患儿的早期功能和代谢紊乱。
Pediatr Endocrinol Diabetes Metab. 2021;27(3):170-177. doi: 10.5114/pedm.2021.107720.
6
Sex-Related Differences in Cardiovascular Disease Risk Profile in Children and Adolescents with Type 1 Diabetes.性别相关差异在 1 型糖尿病患儿和青少年心血管疾病风险特征中的表现。
Int J Mol Sci. 2021 Sep 22;22(19):10192. doi: 10.3390/ijms221910192.
7
Cardiovascular Risk Management in Type 1 Diabetes.1 型糖尿病的心血管风险管理。
Curr Diab Rep. 2021 Aug 26;21(9):29. doi: 10.1007/s11892-021-01400-9.
8
Emerging Targets for Cardiovascular Disease Prevention in Diabetes.糖尿病患者心血管疾病防治的新兴靶点。
Trends Mol Med. 2020 Aug;26(8):744-757. doi: 10.1016/j.molmed.2020.03.011. Epub 2020 May 15.
9
Serum uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes.血清尿调蛋白与 1 型糖尿病青少年的尿白蛋白排泄量有关。
J Diabetes Complications. 2019 Sep;33(9):648-650. doi: 10.1016/j.jdiacomp.2019.05.023. Epub 2019 Jun 3.
10
Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement.Coro2b,一种在人类糖尿病肾病中下调的足细胞蛋白,参与了鱼精蛋白硫酸盐诱导的足突消失的发展。
Sci Rep. 2019 Jun 20;9(1):8888. doi: 10.1038/s41598-019-45303-y.
社区居住的老年人的肾功能与冠状动脉钙进展(来自 Rancho Bernardo 研究)。
Am J Cardiol. 2012 Nov 15;110(10):1425-33. doi: 10.1016/j.amjcard.2012.06.053. Epub 2012 Aug 8.
4
Estimating glomerular filtration rate from serum creatinine and cystatin C.基于血清肌酐和胱抑素 C 估算肾小球滤过率。
N Engl J Med. 2012 Jul 5;367(1):20-9. doi: 10.1056/NEJMoa1114248.
5
Early detection of kidney disease in type 1 diabetes: what do we really know?1型糖尿病患者肾脏疾病的早期检测:我们究竟了解多少?
Diabetes Technol Ther. 2012 Jul;14(7):541-4. doi: 10.1089/dia.2012.0089. Epub 2012 Apr 27.
6
Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis.1 型糖尿病患者肾脏疾病发展中的性别差异:当代分析。
Am J Kidney Dis. 2011 Oct;58(4):565-73. doi: 10.1053/j.ajkd.2011.05.025. Epub 2011 Aug 15.
7
Systematic shifts in cystatin C between 2006 and 2010.2006 年至 2010 年间胱抑素 C 的系统变化。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1952-5. doi: 10.2215/CJN.11271210. Epub 2011 Jul 22.
8
Added value of CAC in risk stratification for cardiovascular events: a systematic review.冠状动脉钙化积分在心血管事件风险分层中的价值:系统评价。
Eur J Clin Invest. 2012 Jan;42(1):110-6. doi: 10.1111/j.1365-2362.2011.02555.x. Epub 2011 Jun 6.
9
Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006.1990 年至 2006 年间,2 至 5 岁发病的 1 型糖尿病青少年的微血管并发症评估。
Pediatr Diabetes. 2011 Dec;12(8):682-9. doi: 10.1111/j.1399-5448.2011.00762.x. Epub 2011 Mar 24.
10
Progression of coronary artery calcium predicts all-cause mortality.冠状动脉钙进展可预测全因死亡率。
JACC Cardiovasc Imaging. 2010 Dec;3(12):1229-36. doi: 10.1016/j.jcmg.2010.08.018.